Blog: Patient Insights & Thought Leadership

Healthcare Industry Thought Leadership

Health Union’s data-driven industry conversations help pharma make smarter, more effective decisions.
Check out our latest thought leadership pieces below.

Differences in DMT treatment experiences among people with MS: Here’s what patients say

July 30, 2018

For many people living with multiple sclerosis (MS), treatment decisions can often be nuanced and complicated. In April of 2018, the American Academy of Neurology (AAN) released new guidelines about when to begin, change, and end disease-modifying therapies (DMTs) for MS patients. MS In America 2018 results may help the healthcare industry gain a broader understanding of people’s experiences, or lack thereof, with DMTs and other MS treatment options.

WHITEPAPER DOWNLOAD: #authenticity How Social Media Can Fuel Growth-Oriented, Sustainable Online Communities

June 28, 2018

Download the full free whitepaper, "#authenticity How Social Media Can Fuel Growth-Oriented, Sustainable Online Communities"

Expanding Patient Voices and Understanding Their Perspectives

Patient Centricity Starts With Patients: Closing the Trial Recruitment Gap

June 27, 2018

There is a lot of talk in the industry about patient centricity, but is it the reality? We talk about putting the needs of patients first and keeping them central in the business decisions we make across the healthcare industry. However, as we discussed on a panel at this year’s DIA 2018 Global Annual Meeting, somehow in the effort to amplify patient centricity, a critical voice is often underrepresented—the voice of the patient.

Building Relationships vs. Publishing Content: Reflecting on the Renewed Interest In Migraine Disease

June 1, 2018

A new class of migraine drugs, called anti-CGRPs (calcitonin gene-related peptide) are expected to reinvigorate a market that has been largely dormant for some time. Four biopharma companies, Amgen, Teva, Lilly and Alder are entering the fray. Not surprisingly, the intense competition and pharma investment associated with this market dynamic has led traditional “eyeball driven” publishers, like WebMD, Everyday Health and others on a quest to offer substantially more migraine-related content in reaction to this market opportunity.

Connecting Across Communities: Health Union Conference for Patient Advocacy Kicks Off in Philadelphia

April 5, 2018

On March 26, 2018 Health Union opened the doors of its new event center in Philadelphia for the second annual HU Connexion, a conference for patient advocacy, to gather and thank the extraordinary network of patient advocates who share their experiences and journeys with thousands of people every day as moderators and contributors for its online communities.

SCOPE 2018: Online Health Communities Fill Gap Between What Patients Want, Researchers Need

February 23, 2018

Online communities fill a void for people with chronic health conditions, offering information, emotional support and connection to others with common experiences. By fostering relationships with members of these online health communities – through relevant content and engaging social conversations that touch on and validate the personal experiences of living with certain chronic conditions – Health Union has the rare opportunity to more accurately understand the concerns of people with these conditions.

WebMD Sale Reflects Trend towards Smarter Spending in Pharma Advertising

August 1, 2017

Last month, headline writers had a field day dreaming up puns for coverage about several pharmaceutical companies’ decision not to run ads for erectile dysfunction drugs during this season’s NFL broadcasts. And, while a connection to the recent sale of WebMD might not be immediately obvious, upon closer examination, these stories share a common theme. Both reflect the shifting sands beneath the pharmaceutical industry and how, in reacting to them, its marketers are being challenged to do more with less.

Online Health Communities: A New Frontier in Health Research

October 3, 2016

As we transcend into the Health 2.0 ecosystem, where the notion of patients using technologies to take control of their personal wellbeing has become more commonplace, our entire global healthcare system has begun to shift.

Healthcare Industry Thought Leadership

Contact